THING ON ENT (02292) announced its interim results for 2025, reporting revenue of HK$17.185 million, a decrease of 7.44% compared to the same period last year. The company recorded a net loss of HK$23.271 million, representing a 57.86% narrowing year-on-year. Loss per share was HK$0.0323. According to the announcement, the loss was primarily attributable to fair value losses on investment properties of approximately HK$31.3 million during the period (2024: HK$65.3 million).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.